Aspiriant LLC Sells 49,052 Shares of iShares Core Growth Allocation ETF (NYSEARCA:AOR)

Aspiriant LLC trimmed its holdings in shares of iShares Core Growth Allocation ETF (NYSEARCA:AORFree Report) by 10.6% in the first quarter, according to its most recent filing with the SEC. The firm owned 414,900 shares of the company’s stock after selling 49,052 shares during the period. iShares Core Growth Allocation ETF makes up about 1.0% of Aspiriant LLC’s investment portfolio, making the stock its 17th biggest position. Aspiriant LLC owned 1.13% of iShares Core Growth Allocation ETF worth $23,098,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. New Capital Management LP increased its position in iShares Core Growth Allocation ETF by 2.3% in the 1st quarter. New Capital Management LP now owns 8,033 shares of the company’s stock valued at $447,000 after acquiring an additional 182 shares in the last quarter. Capital Insight Partners LLC increased its position in iShares Core Growth Allocation ETF by 0.7% in the 4th quarter. Capital Insight Partners LLC now owns 28,862 shares of the company’s stock valued at $1,535,000 after acquiring an additional 191 shares in the last quarter. Beacon Financial Advisory LLC increased its position in iShares Core Growth Allocation ETF by 2.0% in the 4th quarter. Beacon Financial Advisory LLC now owns 9,764 shares of the company’s stock valued at $519,000 after acquiring an additional 195 shares in the last quarter. Lincoln National Corp increased its position in iShares Core Growth Allocation ETF by 1.4% in the 4th quarter. Lincoln National Corp now owns 14,410 shares of the company’s stock valued at $766,000 after acquiring an additional 203 shares in the last quarter. Finally, Geneos Wealth Management Inc. increased its position in iShares Core Growth Allocation ETF by 15.0% in the 4th quarter. Geneos Wealth Management Inc. now owns 1,563 shares of the company’s stock valued at $83,000 after acquiring an additional 204 shares in the last quarter.

iShares Core Growth Allocation ETF Trading Down 0.2 %

AOR opened at $56.40 on Thursday. The stock has a market capitalization of $2.04 billion, a PE ratio of 17.06 and a beta of 0.62. iShares Core Growth Allocation ETF has a 1-year low of $47.56 and a 1-year high of $56.67. The firm has a 50-day moving average price of $55.37 and a two-hundred day moving average price of $54.40.

iShares Core Growth Allocation ETF Company Profile

(Free Report)

iShares Growth Allocation ETF, formerly iShares S&P Growth Allocation Fund (the Fund), is an open-end management investment company. The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Target Risk Growth Index (the Growth Allocation Index). The Growth Allocation Index seeks to measure the performance of an asset allocation strategy targeted to a growth-focused risk profile.

Further Reading

Want to see what other hedge funds are holding AOR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Core Growth Allocation ETF (NYSEARCA:AORFree Report).

Institutional Ownership by Quarter for iShares Core Growth Allocation ETF (NYSEARCA:AOR)

Receive News & Ratings for iShares Core Growth Allocation ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Core Growth Allocation ETF and related companies with MarketBeat.com's FREE daily email newsletter.